Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases — Stella

Recruiting

Back to Muscular Ventricular Septal Defect trials

Trial locations(5 sites)

Ireland

Children's Health Ireland, Dublin

Turkey (Türkiye)

İzmir Şehir Hastanesi, Izmir, Bayraklı

Eskişehir Osmangazi Üniversite Hastanesi, Eskişehir, Odunpazarı

Dicle Üniversitesi Tıp Fakültesi Hastanesi, Diyarbakır, Sur

Gaziantep Unıversıty Hospital, Gaziantep, Şehitkamil

Key details

Sponsor

Occlutech International AB

Enrollment target

~50 participants

Started

March 2022

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

3 Months – 80 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov